{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:16:27Z","timestamp":1785838587863,"version":"3.56.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1136\/ijgc-2020-001540","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T01:45:13Z","timestamp":1597283113000},"page":"110-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Arthralgia in patients with ovarian cancer treated with bevacizumab and chemotherapy"],"prefix":"10.1016","volume":"31","clinical-trial-number":[{"clinical-trial-number":"nct03038100","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jole","family":"Ventriglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immacolata","family":"Paciolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Tambaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Chiara","family":"Cecere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena","family":"Di Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Attademo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Arenare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Califano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzia Simona","family":"Losito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Venanzio","family":"Setola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisena","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Orditura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Pignata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001540_bb0010","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/annonc\/mdx011","article-title":"Fifth ovarian cancer consensus conference of the gynecologic cancer intergroup: first-line interventions","volume":"28","author":"Karam","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2020-001540_bb0015","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","article-title":"Incorporation of bevacizumab in the primary treatment of ovarian cancer","volume":"365","author":"Burger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2020-001540_bb0020","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S1470-2045(15)00086-8","article-title":"Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial","volume":"16","author":"Oza","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2020-001540_bb0025","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1200\/JCO.19.01009","article-title":"Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer","volume":"37","author":"Tewari","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001540_bb0030","doi-asserted-by":"crossref","first-page":"12389","DOI":"10.18632\/oncotarget.13310","article-title":"Bevacizumab in ovarian cancer: a critical review of phase III studies","volume":"8","author":"Rossi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1136\/ijgc-2020-001540_bb0035","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1093\/annonc\/mdq767","article-title":"Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with bevacizumab in subjects with advanced solid tumors","volume":"22","author":"Langenberg","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2020-001540_bb0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1200\/JCO.2007.12.1939","article-title":"Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia","volume":"26","author":"Garcia","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001540_bb0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10985-006-9004-2","article-title":"Dynamic path analysis-a new approach to analyzing time-dependent covariates","volume":"12","author":"Fosen","year":"2006","journal-title":"Lifetime Data Anal"},{"key":"10.1136\/ijgc-2020-001540_bb0050","author":"Marubini","year":"1995"},{"key":"10.1136\/ijgc-2020-001540_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2020-001540_bb0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2020-001540_bb0065","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(06)69446-4","article-title":"Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial","volume":"368","author":"Demetri","year":"2006","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2020-001540_bb0070","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.2147\/OTT.S61132","article-title":"Ramucirumab: preclinical research and clinical development","volume":"7","author":"Aprile","year":"2014","journal-title":"Onco Targets Ther"},{"key":"10.1136\/ijgc-2020-001540_bb0075","doi-asserted-by":"crossref","first-page":"17246","DOI":"10.18632\/oncotarget.12825","article-title":"Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study","volume":"8","author":"Luo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1136\/ijgc-2020-001540_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00426","article-title":"Bevacizumab dose affects the severity of adverse events in gynecologic malignancies","volume":"10","author":"Lee","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1136\/ijgc-2020-001540_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.nbd.2014.08.012","article-title":"Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia","volume":"71","author":"Hulse","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1136\/ijgc-2020-001540_bb0090","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1093\/brain\/aws145","article-title":"Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy","volume":"135","author":"Verheyen","year":"2012","journal-title":"Brain"},{"key":"10.1136\/ijgc-2020-001540_bb0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuroscience.2013.03.050","article-title":"Therapeutic potential of VEGF and VEGF-derived peptide in peripheral neuropathies","volume":"244","author":"Verheyen","year":"2013","journal-title":"Neuroscience"},{"key":"10.1136\/ijgc-2020-001540_bb0100","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ajpath.2013.05.031","article-title":"VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro","volume":"183","author":"Beazley-Long","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1136\/ijgc-2020-001540_bb0105","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1158\/1078-0432.CCR-06-2416","article-title":"Vascular endothelial growth factor and its relationship to inflammatory mediators","volume":"13","author":"Angelo","year":"2007","journal-title":"Clin Cancer Res"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24026008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24026008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001540","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:37:54Z","timestamp":1753223874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24026008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1048891X24026008"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001540","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arthralgia in patients with ovarian cancer treated with bevacizumab and chemotherapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}